<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00299429</url>
  </required_header>
  <id_info>
    <org_study_id>2-Thiele</org_study_id>
    <nct_id>NCT00299429</nct_id>
  </id_info>
  <brief_title>MIDCAB Versus DES in Proximal LAD Lesions</brief_title>
  <official_title>Randomised Comparison of Minimally Invasive Direct Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Proximal Stenosis of the Left Anterior Descending Coronary Artery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cordis Medizinische Apparate GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Percutaneous coronary intervention with a sirolimus-coated stent compared to minimally
      invasive bypass surgery in patients with isolated proximal left anterior descending coronary
      arteries in terms of non-inferiority of an end point combining mortality, acute myocardial
      infarction and rate of reintervention of the target vessel within one year.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative complications</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CCS-Classification</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost-effectiveness</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">130</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stenting and minimally invasive bypass surgery</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Single-vessel disease of the proximal LAD with a stenosis &gt; 50% (multivessel disease
             only if further coronary vessel stenoses do not require treatment)

          2. Patients with angina pectoris (CCS 1-4)

          3. Asymptomatic patients if clear signs of ischemia in the segments supplied by the LAD
             as assessed by bicycle ergometry or treadmill and/or scintigraphically and/or stress
             echo

          4. Patients for whom both methods of treatment are equally possible

          5. Consensus between the cardiac surgeon and the cardiologist that both inclusion and
             exclusion criteria are met in the selected case

          6. Informed consent of the patient.

        Exclusion Criteria:

          1. Patients &lt; 18 years

          2. Pregnancy

          3. Previous coronary artery bypass surgery

          4. Concomitant diseases that lead to a greater risk for each of the treatment strategies

          5. Significant peripheral arterial occlusive disease

          6. Concomitant disease with limited life expectancy (e.g. malignant tumours that have not
             been curatively treated)

          7. Objective follow-up examination not possible due to physical or mental handicap

          8. Participation in another study.

        Angiographical exclusion criteria:

          1. Left main stem stenosis

          2. Multivessel disease for which surgical or interventional therapy on other vessel areas
             is required.

          3. Diagonal/septal branch &gt; 1.5 mm, which might be compromised by a stent

          4. Need for acute intervention (e.g. acute myocardial infarction)

          5. Total occlusion of the LAD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holger Thiele, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heartcenter Leipzig GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Leipzig - Heart Center</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>March 3, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2006</study_first_posted>
  <last_update_submitted>July 7, 2008</last_update_submitted>
  <last_update_submitted_qc>July 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Holger Thiele</name_title>
    <organization>University of Leipzig - Heart Center</organization>
  </responsible_party>
  <keyword>Stent</keyword>
  <keyword>drug-eluting stent</keyword>
  <keyword>Minimally invasive bypass surgery</keyword>
  <keyword>left anterior descending</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

